Skip to main content

Advertisement

SpringerLink
Log in

Gyrate atrophy: clinical and genetic findings in a female without arginine-restricted diet during her first 39 years of life and report of a new OAT gene mutation

  • Original Research Article
  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

We report the clinical and genetic data obtained at a 17-year follow-up examination of a patient with gyrate atrophy, without an arginine-restricted diet. Patient examinations included visual acuity (VA), perimetry, biomicroscopy, funduscopy, fundus photography, fundus autofluorescence (FAF), spectral-domain optical coherence tomography (OCT), and standard full-field electroretinography (ERG). Blood samples were taken for measurement of serum ornithine level and molecular genetic analysis of the OAT gene. The female was 22 years of age when gyrate atrophy was diagnosed based on peripheral chorioretinal atrophy and an increased ornithine level. Reexamination after 17 years revealed a reduced VA (0.25 OU), dense cataract, extensive peripheral chorioretinal atrophy, a further increased ornithine level, but only slow progression of visual field constriction, and still detectable ERG amplitudes. FAF was absent in the atrophic periphery and almost homogeneous at the posterior pole except parafoveally. OCT showed interruption of the foveal inner/outer segment junction and parafoveal microcystoid spaces. After cataract surgery, VA increased to the same values as those found at the age of 22 years (0.5 OD, 0.6 OS). Molecular analysis revealed a new deletion c.532_536delTGGGG (p.Trp178X) and a known mutation c.897C>G (p.Tyr299X) in the OAT gene. Although the patient had refused to diet during her first 39 years of life, the gyrate atrophy showed a very slow progression. FAF allows evaluating the integrity of the retinal pigment epithelium and may help to delimit gyrate atrophy from choroideremia. Interruption of foveal inner/outer segment junction and cystoid macula edema appears in gyrate atrophy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Valle D, Simell O (2001) The hyperornithinaemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1857–1895

    Google Scholar 

  2. Mitchell GA, Looney JE, Brody LC, Steel G, Suchanek M, Engelhardt JF, Willard HF, Valle D (1988) Human ornithine-delta-aminotransferase. cDNA cloning and analysis of the structural gene. J Biol Chem 263:14288–14295

    PubMed  CAS  Google Scholar 

  3. Ramesh V, Benoit LA, Crawford P, Harvey PT, Shows TB, Shih VE, Gusella JF (1988) The ornithine aminotransferase (OAT) locus: analysis of RFLPs in gyrate atrophy. Am J Hum Genet 42:365–372

    PubMed  CAS  Google Scholar 

  4. Wu J, Ramesh V, Kidd JR, Castiglione CM, Myers S, Carson N, Anderson L, Gusella JF, Simpson NE, Kidd KK (1988) The ornithine aminotransferase (OAT) locus is linked and distal to D10S20 on the long arm of chromosome 10. Cytogenet Cell Genet 48:126–127

    Article  PubMed  CAS  Google Scholar 

  5. Rao GN, Cotlier E (1984) Ornithine delta-aminotransferase activity in retina and other tissues. Neurochem Res 9:555–562

    Article  PubMed  CAS  Google Scholar 

  6. Ratzlaff K, Baich A (1987) Comparison of ornithine aminotransferase activities in the pigment epithelium and retina of vertebrates. Comp Biochem Physiol B 88:35–37

    Article  PubMed  CAS  Google Scholar 

  7. Bernstein SL, Wong P (1998) Regional expression of disease-related genes in human and monkey retina. Mol Vis 4:24

    PubMed  CAS  Google Scholar 

  8. O’Donnell JJ, Sandman RP, Martin SR (1978) Gyrate atrophy of the retina: inborn error of L-ornithin: 2-oxoacid aminotransferase. Science 200:200–201

    Article  PubMed  Google Scholar 

  9. Simell O, Takki K (1973) Raised plasma-ornithine and gyrate atrophy of the choroid and retina. Lancet 1:1031–1033

    Article  PubMed  CAS  Google Scholar 

  10. Takki K, Simell O (1974) Genetic aspects in gyrate atrophy of the choroid and retina with hyperornithinaemia. Br J Ophthalmol 58:907–916

    Article  PubMed  CAS  Google Scholar 

  11. Takki K (1974) Gyrate atrophy of the choroid and retina associated with hyperornithinaemia. Br J Ophthalmol 58:3–23

    Article  PubMed  CAS  Google Scholar 

  12. Vannas-Sulonen K, Sipila I, Vannas A, Simell O, Rapola J (1985) Gyrate atrophy of the choroid and retina. A five-year follow-up of creatine supplementation. Ophthalmology 92:1719–1727

    PubMed  CAS  Google Scholar 

  13. Kaiser-Kupfer MI, de Monasterio FM, Valle D, Walser M, Brusilow S (1980) Gyrate atrophy of the choroid and retina: improved visual function following reduction of plasma ornithine by diet. Science 210:1128–1131

    Article  PubMed  CAS  Google Scholar 

  14. Kaiser-Kupfer MI, de Monasterio F, Valle D, Walser M, Brusilow S (1981) Visual results of a long-term trial of a low-arginine diet in gyrate atrophy of choroid and retina. Ophthalmology 88:307–310

    PubMed  CAS  Google Scholar 

  15. Kaiser-Kupfer MI, Caruso RC, Valle D (1991) Gyrate atrophy of the choroid and retina. Long-term reduction of ornithine slows retinal degeneration. Arch Ophthalmol 109:1539–1548

    Article  PubMed  CAS  Google Scholar 

  16. Kaiser-Kupfer MI, Caruso RC, Valle D (2002) Gyrate atrophy of the choroid and retina: further experience with long-term reduction of ornithine levels in children. Arch Ophthalmol 120:146–153

    Article  PubMed  Google Scholar 

  17. Kaiser-Kupfer MI, Caruso RC, Valle D, Reed GF (2004) Use of an arginine-restricted diet to slow progression of visual loss in patients with gyrate atrophy. Arch Ophthalmol 122:982–984

    Article  PubMed  Google Scholar 

  18. Valle D, Walser M, Brusilow SW, Kaiser-Kupfer M (1980) Gyrate atrophy of the choroid and retina: amino acid metabolism and correction of hyperornithinaemia with an arginine-deficient diet. J Clin Invest 65:371–378

    Article  PubMed  CAS  Google Scholar 

  19. Valle D, Walser M, Brusilow S, Kaiser-Kupfer MI, Takki K (1981) Gyrate atrophy of the choroid and retina. Biochemical considerations and experience with an arginine-restricted diet. Ophthalmology 88:325–330

    PubMed  CAS  Google Scholar 

  20. Weleber RG, Kennaway NG, Buist NR (1981) Gyrate atrophy of the choroid and retina. Approaches to therapy. Int Ophthalmol 4:23–32

    Article  PubMed  CAS  Google Scholar 

  21. Santinelli R, Costagliola C, Tolone C, D’Aloia A, D’Avanzo A, Prisco F, Perrone L, del Giudice EM (2004) Low-protein diet and progression of retinal degeneration in gyrate atrophy of the choroid and retina: a twenty-six-year follow-up. J Inherit Metab Dis 27:187–196

    Article  PubMed  CAS  Google Scholar 

  22. Weleber RG (2006) Gyrate atrophy of the choroid and retina. In: Heckenlively JR, Arden GB (eds) Principles and practice of clinical electrophysiology of vision. The MIT Press, Cambridge, pp 705–715

    Google Scholar 

  23. McCulloch C, Marliss EB (1975) Gyrate atrophy of the choroid and retina: clinical, ophthalmologic, and biochemical considerations. Trans Am Ophthalmol Soc 73:153–171

    PubMed  CAS  Google Scholar 

  24. Takki KK, Milton RC (1981) The natural history of gyrate atrophy of the choroid and retina. Ophthalmology 88:292–301

    PubMed  CAS  Google Scholar 

  25. Kaiser-Kupfer M, Kuwabara T, Uga S, Takki K, Valle D (1983) Cataract in gyrate atrophy: clinical and morphologic studies. Invest Ophthalmol Vis Sci 24:432–436

    PubMed  CAS  Google Scholar 

  26. Oliveira TL, Andrade RE, Muccioli C, Sallum J, Belfort R Jr (2005) Cystoid macular edema in gyrate atrophy of the choroid and retina: a fluorescein angiography and optical coherence tomography evaluation. Am J Ophthalmol 140:147–149

    Article  PubMed  Google Scholar 

  27. Vasconcelos-Santos DV, Magalhaes EP, Nehemy MB (2007) Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case report. Arq Bras Oftalmol 70:858–861

    Article  PubMed  Google Scholar 

  28. Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2009) ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 118:69–77

    Article  PubMed  CAS  Google Scholar 

  29. Peltola KE, Nanto-Salonen K, Heinonen OJ, Jaaskelainen S, Heinanen K, Simell O, Nikoskelainen E (2001) Ophthalmologic heterogeneity in subjects with gyrate atrophy of choroid and retina harboring the L402P mutation of ornithine aminotransferase. Ophthalmology 108:721–729

    Article  PubMed  CAS  Google Scholar 

  30. Kaiser-Kupfer MI, Valle D, Bron AJ (1980) Clinical and biochemical heterogeneity in gyrate atrophy. Am J Ophthalmol 89:219–222

    PubMed  CAS  Google Scholar 

  31. Hayasaka S, Shiono T, Mizuno K, Sasayama C, Akiya S, Tanaka Y, Hayakawa M, Miyake Y, Ohba N (1986) Gyrate atrophy of the choroid and retina: 15 Japanese patients. Br J Ophthalmol 70:612–614

    Article  PubMed  CAS  Google Scholar 

  32. Kaiser-Kupfer MI, Ludwig IH, de Monasterio FM, Valle D, Krieger I (1985) Gyrate atrophy of the choroid and retina. Early findings. Ophthalmology 92:394–401

    PubMed  CAS  Google Scholar 

  33. Raitta C, Carlson S, Vannas-Sulonen K (1990) Gyrate atrophy of the choroid and retina: ERG of the neural retina and the pigment epithelium. Br J Ophthalmol 74:363–367

    Article  PubMed  CAS  Google Scholar 

  34. Caruso RC, Nussenblatt RB, Csaky KG, Valle D, Kaiser-Kupfer MI (2001) Assessment of visual function in patients with gyrate atrophy who are considered candidates for gene replacement. Arch Ophthalmol 119:667–669

    PubMed  CAS  Google Scholar 

  35. Vannas-Sulonen K (1987) Progression of gyrate atrophy of the choroid and retina. A long-term follow-up by fluorescein angiography. Acta Ophthalmol (Copenh) 65:101–109

    Article  CAS  Google Scholar 

  36. Feldman RB, Mayo SS, Robertson DM, Jones JD, Rostvold JA (1989) Epiretinal membranes and cystoid macular edema in gyrate atrophy of the choroid and retina. Retina 9:139–142

    Article  PubMed  CAS  Google Scholar 

  37. Renner AB, Kellner U, Cropp E, Preising MN, MacDonald IM, van den Hurk JA, Cremers FP, Foerster MH (2006) Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram. Ophthalmology 113:2066 e2061–2010

    Google Scholar 

  38. Renner AB, Fiebig BS, Cropp E, Weber BH, Kellner U (2009) Progression of retinal pigment epithelial alterations during long-term follow-up in female carriers of choroideremia and report of a novel CHM mutation. Arch Ophthalmol 127:907–912

    Article  PubMed  CAS  Google Scholar 

  39. Preising MN, Wegscheider E, Friedburg C, Poloschek CM, Wabbels BK, Lorenz B (2009) Fundus autofluorescence in carriers of choroideremia and correlation with electrophysiologic and psychophysical data. Ophthalmology 116(1201–1209):e1201–e1202

    Article  Google Scholar 

  40. Poloschek CM, Kloeckener-Gruissem B, Hansen LL, Bach M, Berger W (2008) Syndromic choroideremia: sublocalization of phenotypes associated with Martin-Probst deafness mental retardation syndrome. Invest Ophthalmol Vis Sci 49:4096–4104

    Article  PubMed  Google Scholar 

  41. Mashima Y, Murakami A, Weleber RG, Kennaway NG, Clarke L, Shiono T, Inana G (1992) Nonsense-codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy. Am J Hum Genet 51:81–91

    PubMed  CAS  Google Scholar 

  42. Dietz HC, Valle D, Francomano CA, Kendzior RJ Jr, Pyeritz RE, Cutting GR (1993) The skipping of constitutive exons in vivo induced by nonsense mutations. Science 259:680–683

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany

    Agnes B. Renner, Andreas Walter & Herbert Jägle

  2. Augenklinik Krankenhaus Dresden-Friedrichstadt, Friedrichstr. 41, 01067, Dresden, Germany

    Andreas Walter

  3. Institut für Humangenetik, Universität Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany

    Britta S. Fiebig

Authors
  1. Agnes B. Renner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Walter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Britta S. Fiebig
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Herbert Jägle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Agnes B. Renner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Renner, A.B., Walter, A., Fiebig, B.S. et al. Gyrate atrophy: clinical and genetic findings in a female without arginine-restricted diet during her first 39 years of life and report of a new OAT gene mutation. Doc Ophthalmol 125, 81–89 (2012). https://doi.org/10.1007/s10633-012-9335-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10633-012-9335-0

Keywords

Search

Navigation